<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Interstitial deletion or loss of chromosome 5 is frequent in malignant myeloid disorders, including <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), suggesting the presence of a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene </plain></SENT>
<SENT sid="1" pm="."><plain>Loss of heterozygosity (LOH) analysis was used to define a minimal deletion interval for this gene </plain></SENT>
<SENT sid="2" pm="."><plain>Polymorphic markers on 5q31 were identified using a high-resolution physical and radiation hybrid breakpoint map and applied to a patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> with a subcytogenetic deletion of 5q </plain></SENT>
<SENT sid="3" pm="."><plain>By comparing the DNA from leukemic cells to buccal mucosa cells, LOH was detected with markers D5S476 and D5S1372 with retention of flanking markers D5S500 to D5S594 </plain></SENT>
<SENT sid="4" pm="."><plain>The D5S500-D5S594 interval, which covers approximately 700 kb, thus represents a minimal localization for the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene </plain></SENT>
<SENT sid="5" pm="."><plain>Further refinement of the physical map enabled the specification of 9 transcription units within the encompassing radiation hybrid bins and 7 in flanking bins </plain></SENT>
<SENT sid="6" pm="."><plain>The 9 candidates include genes CDC25, HSPA9, EGR1, CTNNA1, and 5 unknown ESTs </plain></SENT>
<SENT sid="7" pm="."><plain>Reverse-transcription polymerase chain reaction confirms that <z:hpo ids='HP_0000001'>all</z:hpo> of them are expressed in <z:mpath ids='MPATH_458'>normal</z:mpath> human bone marrow CD34(+) cells and in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> cell lines and thus represent likely candidates for the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene at 5q31 </plain></SENT>
</text></document>